TY - JOUR
T1 - Safety assessment of Detarium microcarpum Guil. & Perr. (Leguminosae) root bark extract in rats
T2 - Acute, sub-acute toxicity, ADMET, molecular docking, and molecular dynamics simulations approach
AU - Mbock, Michel Arnaud
AU - Kamkumo, Raceline Gounoue
AU - Iqbal, Naveed
AU - Feudjou Fouatio, William
AU - Shukla, Rohit
AU - Chandra, Anshuman
AU - Tsouh Fokou, Patrick Valère
AU - Ngueguim Tsofack, Florence
AU - Bibi, Ishrat
AU - Fekam Boyom, Fabrice
AU - Essia Ngang, Jean Justin
AU - Boyomo, Onana
AU - Nganso Ditchou, Yves Oscar
AU - Nkengfack, Augustin Ephrem
AU - Lenta Ndjakou, Bruno
AU - Sewald, Norbert
AU - Siwe Noundou, Xavier
AU - Dimo, Théophile
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/7
Y1 - 2025/7
N2 - Since the last decades, Detarium microcarpum have been used and studied due to the significant properties to threat various ailments. It is therefore crucial to ascertain the safety properties of is phytoconstituents. The present study was taken up to investigate the oral acute toxicity, 28 days repeated oral sub-acute toxicity study of D. microcarpum root bark extract in Albino Wistar rats, molecular docking, and molecular dynamic simulation. Based on acute oral toxicity, the LD50 value of the extract was considered “non-toxic” up to a 5000 mg/kg b.w. The regular administration of the extract post 28-day treatment was also qualified as safe based on the body and organ weight, hematological, biochemical, and histopathological results in the sub-acute toxicity assay. The majority of the previous identified and isolated compounds passed the ADMET analysis, and the molecular docking identified 1,7-dihydroxy-6-methylxanthone (15) as the top one candidate with an effective binding affinity of −8.1, and − 7.5 (kcal/mol), for P450 and UGT2B7 proteins respectively. This compound was then further assessed using MD simulation, which verified the molecule's stability and binding to the targeted protein. Collectively these data build the foundation of support demonstrating that D. microcarpum root bark extract could be considered as a promising medicinal drug and concluded its suitable used for pharmacological purposes.
AB - Since the last decades, Detarium microcarpum have been used and studied due to the significant properties to threat various ailments. It is therefore crucial to ascertain the safety properties of is phytoconstituents. The present study was taken up to investigate the oral acute toxicity, 28 days repeated oral sub-acute toxicity study of D. microcarpum root bark extract in Albino Wistar rats, molecular docking, and molecular dynamic simulation. Based on acute oral toxicity, the LD50 value of the extract was considered “non-toxic” up to a 5000 mg/kg b.w. The regular administration of the extract post 28-day treatment was also qualified as safe based on the body and organ weight, hematological, biochemical, and histopathological results in the sub-acute toxicity assay. The majority of the previous identified and isolated compounds passed the ADMET analysis, and the molecular docking identified 1,7-dihydroxy-6-methylxanthone (15) as the top one candidate with an effective binding affinity of −8.1, and − 7.5 (kcal/mol), for P450 and UGT2B7 proteins respectively. This compound was then further assessed using MD simulation, which verified the molecule's stability and binding to the targeted protein. Collectively these data build the foundation of support demonstrating that D. microcarpum root bark extract could be considered as a promising medicinal drug and concluded its suitable used for pharmacological purposes.
KW - ADMET
KW - Acute toxicity
KW - Detarium microcarpum
KW - Molecular docking
KW - Molecular dynamics simulation (MDS)
KW - Sub-acute toxicity
UR - https://www.scopus.com/pages/publications/105005495200
U2 - 10.1016/j.fitote.2025.106635
DO - 10.1016/j.fitote.2025.106635
M3 - Article
C2 - 40398517
AN - SCOPUS:105005495200
SN - 0367-326X
VL - 184
JO - Fitoterapia
JF - Fitoterapia
M1 - 106635
ER -